Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?

Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465 · see citing works

Adipokines: inflammation and the pleiotropic role of white adipose tissue

Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210 · see citing works

Novel Modulator for Endothelial Adhesion Molecules

Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,139 · see citing works

Impact of Aortic Stiffness on Survival in End-Stage Renal Disease

Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E., & London, G. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2434 · Cited by 2,138 · see citing works

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Caterina, R. D., Libby, P., Peng, H., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,781 · see citing works

Hyperinsulinemia as an independent risk factor for ischemic heart disease

Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699 · see citing works

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients

Blacher, J., Asmar, R., Djane, S., London, G. M., & Safar, M. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1111 · Cited by 1,493 · see citing works

Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

Staels, B., Köenig, W., Habib, A., Merval, R., Lebret, M., Pineda‐Torra, I., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134 · see citing works

Adiponectin and protection against type 2 diabetes mellitus

Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120 · see citing works

Arterial stiffness, wave reflections, and the risk of coronary artery disease

Weber, T., Auer, J., O’Rourke, M. F., Kvas, E., Lassnig, E., Berent, R., & Eber, B. (2004) · Circulation · doi:10.1161/01.cir.0000105767.94169.e3 · Cited by 1,081 · see citing works

An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man

KARAMANOGLU, M., O'ROURKE, M. F., AVOLIO, A. P., & KELLY, R. P. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.2.160 · Cited by 873 · see citing works

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.

Zeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726 · see citing works

Non–Insulin-Dependent Diabetes Mellitus and Fasting Glucose and Insulin Concentrations Are Associated With Arterial Stiffness Indexes

Salomaa, V. V., Riley, W. A., Kark, J. D., Nardo, C. J., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 580 · see citing works

Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.

Yeni-Komshian, H., Carantoni, M., Abbasi, F., & Reaven, G. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.171 · Cited by 414 · see citing works

Peroxisome Proliferator–Activated Receptor (PPAR)α Activation Increases Adiponectin Receptors and Reduces Obesity-Related Inflammation in Adipose Tissue

Tsuchida, A., Yamauchi, T., Takekawa, S., Hada, Y., Ito, Y., Maki, T., & Kadowaki, T. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3358 · Cited by 410 · see citing works

Peroxisome Proliferator-Activated Receptor γ Ligands Increase Release of Nitric Oxide From Endothelial Cells

Calnek, D. S., Mazzella, L., Roser, S., Roman, J., & Hart, C. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000044461.01844.c9 · Cited by 286 · see citing works

Endothelial function, inflammation, and prognosis in cardiovascular disease

Gonzalez, M. A., & Selwyn, A. P. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.016 · Cited by 258 · see citing works

Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity

Tsigos, C., Kyrou, I., Chala, E., Tsapogas, P., Stavridis, J. C., Raptis, S., & Katsilambros, N. L. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90277-9 · Cited by 233 · see citing works

PPARs in Diseases: Control Mechanisms of Inflammation

Kostadinova, R. M., Wahli, W., & Michalik, L. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774462905 · Cited by 204 · see citing works

Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis

Klocke, R., Cockcroft, J. R., Taylor, G. J., Hall, I. R., & Blake, D. R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.5.414 · Cited by 190 · see citing works

Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells

Goya, K., Sumitani, S., Xu, X., Kitamura, T., Yamamoto, H., Kurebayashi, S., Saito, H., Kouhara, H., Kasayama, S., & Kawase, I. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000118682.58708.78 · Cited by 174 · see citing works

Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes

Tafuri, S. R. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895337 · Cited by 167 · see citing works

Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease

Gable, D. R., Hurel, S. J., & Humphries, S. E. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.010 · Cited by 159 · see citing works

Prevention Conference V

Grundy, S. M., Bazzarre, T. L., Cleeman, J. I., D’Agostino, R. B., Hill, M. N., Miller, N. H., Kannel, W. B., Krauss, R. M., Krumholz, H. M., Lauer, R. M., et al. (2000) · Circulation · doi:10.1161/01.cir.101.1.e3 · Cited by 127 · see citing works

PPARα and GR Differentially Down-Regulate the Expression of Nuclear Factor-κB-Responsive Genes in Vascular Endothelial Cells

Xu, X., Otsuki, M., Saito, H., Sumitani, S., Yamamoto, H., Asanuma, N., Kouhara, H., & Kasayama, S. (2001) · Endocrinology · doi:10.1210/endo.142.8.8340 · Cited by 82 · see citing works

Resistance to Acute Insulin Induced Decreases in Large Artery Stiffness Accompanies the Insulin Resistance Syndrome

Westerbacka, J., Seppälä‐Lindroos, A., & Yki‐Järvinen, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8047 · Cited by 66 · see citing works

The expression of adhesion molecules on endothelial cells is inhibited by troglitazone through its antioxidant activity

Cominacini, L., Garbin, U., Pasini, A. F., Davoli, A., Campagnola, M., Rigoni, A. M., Tosetti, L., & Cascio, V. L. (1999) · Cell Communication & Adhesion · doi:10.3109/15419069909010804 · Cited by 51 · see citing works

Inhibitory effect of pioglitazone on expression of adhesion molecules on neutrophils and endothelial cells

Imamoto, E., Yoshida, N., Uchiyama, K., Kuroda, M., Kokura, S., Ichikawa, H., Naito, Y., Tanigawa, T., & Yoshikawa, T. (2004) · BioFactors · doi:10.1002/biof.5520200104 · Cited by 49 · see citing works

PPAR and GR Differentially Down-Regulate the Expression of Nuclear Factor- B-Responsive Genes in Vascular Endothelial Cells

Xu, X. (2001) · Endocrinology · doi:10.1210/en.142.8.3332 · Cited by 21 · see citing works

Cell adhesion molecules in cardiovascular disease: what can soluble levels tell us?

Blann, A. D., & Lip, G. Y. H. (1999) · Heart · doi:10.1136/hrt.81.1.101 · Cited by 9 · see citing works

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

Keech, A., Mitchell, P., Summanen, P., O'Day, J., Davis, T., Moffitt, M., Taskinen, M.-R., Simes, R., Tse, D., Williamson, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61607-9 · Cited by 1,109 · see citing works

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

Fruchart, J.-C., Sacks, F., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.002 · Cited by 463 · see citing works

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Rajamani, K., Colman, P. G., Li, L. P., Best, J. D., Voysey, M., D'Emden, M. C., Laakso, M., Baker, J. R., & Keech, A. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60698-x · Cited by 328 · see citing works

Strategies for Achieving Healthy Vascular Aging

Nowak, K. L., Rossman, M. J., Chonchol, M., & Seals, D. R. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10439 · Cited by 152 · see citing works

Pharmacological Modulation of Arterial Stiffness

Boutouyrie, P., Lacolley, P. J., Briet, M. B., Regnault, V., Stanton, A. V., Laurent, S., & Mahmud, A. (2011) · Drugs · doi:10.2165/11593790-000000000-00000 · Cited by 147 · see citing works

Arterial Stiffness and Cardiovascular Therapy

Janić, M., Lunder, M., & Šabović, M. (2014) · BioMed Research International · doi:10.1155/2014/621437 · Cited by 145 · see citing works

The Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone Represses Inflammation in a Peroxisome Proliferator-Activated Receptor-α–Dependent Manner In Vitro and In Vivo in Mice

Orasanu, G., Ziouzenkova, O., Devchand, P. R., Nehra, V., Hamdy, O., Horton, E. S., & Plutzky, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.055 · Cited by 129 · see citing works

Cardiovascular Biology of Interleukin-6

Abeywardena, M. Y., Leifert, W. R., Warnes, K., Varghese, J. N., & Head, R. J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788186290 · Cited by 127 · see citing works

Fenofibrate: treatment of hyperlipidemia and beyond

Rosenson, R. S. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.10.1319 · Cited by 110 · see citing works

Review: Role of the augmentation index in hypertension

Shimizu, M., & Kario, K. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944707086935 · Cited by 105 · see citing works

PPARs and Angiogenesis—Implications in Pathology

Wagner, N., & Wagner, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165723 · Cited by 81 · see citing works

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Hiukka, A., Westerbacka, J., Leinonen, E. S., Watanabe, H., Wiklund, O., Hultén, L. M., Salonen, J. T., Tuomainen, T., Yki‐Järvinen, H., KEECH, A. C., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.049 · Cited by 73 · see citing works

Apolipoprotein B-48

Nakajima, K., Nagamine, T., Fujita, M., Ai, M., Tanaka, A., & Schaefer, E. J. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800263-6.00003-3 · Cited by 67 · see citing works

Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats

Mahmoud, A. A. A., & Elshazly, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106993 · Cited by 66 · see citing works

Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study

Tanaka, R., Yamashiro, K., Okuma, Y., Shimura, H., Nakamura, S., Ueno, Y., Tanaka, Y., Miyamoto, N., Tomizawa, Y., Nakahara, T., et al. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.30007 · Cited by 56 · see citing works

Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis

Cash, W. J., O’Neill, S., O’Donnell, M. E., McCance, D. R., Young, I. S., McEneny, J., McDougall, N., & Callender, M. E. (2013) · Liver International · doi:10.1111/liv.12191 · Cited by 56 · see citing works

Association of serum leptin levels with central arterial stiffness in coronary artery disease patients

Tsai, J., Wang, J., Chen, M., Yang, C.-F., Chen, Y., & Hsu, B. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0268-5 · Cited by 51 · see citing works

Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease

Wagner, N., & Wagner, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032345 · Cited by 48 · see citing works

Inflammatory mechanisms linking obesity and tendinopathy

Lui, P. P. Y., & Yung, P. S. (2021) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2021.10.003 · Cited by 45 · see citing works

PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity

Chen, J., Wu, Y., Li, C.-Y., Jheng, H., Kao, L., Yang, C.-C., Leu, S., Lien, I.-C., Weng, W., Tai, H.-C., et al. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00720-y · Cited by 44 · see citing works

Peroxisome proliferator–activated receptor γ agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease

Yu, J., Jin, N., Wang, G., Zhang, F., Mao, J., & Wang, X. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.011 · Cited by 43 · see citing works

Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness

Weiss, E. P., Villareal, D. T., Ehsani, A. A., Fontana, L., & Holloszy, J. O. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00852.x · Cited by 42 · see citing works

Endothelial function, arterial stiffness and lipid lowering drugs

Τζιόμαλος, Κ., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1143 · Cited by 41 · see citing works

Fibrate therapy and circulating adiponectin concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials

Sahebkar, A., & Watts, G. F. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.026 · Cited by 41 · see citing works

Fenofibrate and metabolic syndrome

T. Kraja, A., A. Province, M., J. Straka, R., M. Ordovas, J., B. Borecki, I., & K. Arnett, D. (2010) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213047 · Cited by 40 · see citing works

Unraveling the Links Underlying Arterial Stiffness, Bone Demineralization, and Muscle Loss

Tap, L., Kirkham, F. A., Mattace-Raso, F. U. S., Joly, L., Rajkumar, C., & Bénétos, A. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15184 · Cited by 38 · see citing works

PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets

Zheng, Y., Shao, M., Zheng, Y., Sun, W., Qin, S., Sun, Z., Zhu, L., Guan, Y., Wang, Q., Wang, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.020 · Cited by 37 · see citing works

Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects

Bragt, M. C. E., & Mensink, R. P. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.12.010 · Cited by 36 · see citing works

Pharmacological modulation of vascular ageing: A review from VascAgeNet

Roth, L., Doğan, S., Tuna, B. G., Arányi, T., Benı́tez, S., Borrell-Pagés, M., Bozaykut, P., Meyer, G. R. Y. D., Duca, L., Durmuş, N., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102122 · Cited by 36 · see citing works

MitoNEET in Perivascular Adipose Tissue Blunts Atherosclerosis under Mild Cold Condition in Mice

Xiong, W., Zhao, X., Garcia-Barrio, M. T., Zhang, J., Lin, J. D., Chen, Y., Jiang, Z., & Chang, L. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01032 · Cited by 33 · see citing works

Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials

Simental‐Mendía, L. E., Simental-Mendía, M. A., Sánchez‐García, A., Banach, M., Atkin, S. L., Gotto, A. M., & Sahebkar, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.030 · Cited by 33 · see citing works

MitoNEET in Perivascular Adipose Tissue Prevents Arterial Stiffness in Aging Mice

Chang, L., Zhao, X., Garcia-Barrio, M. T., Zhang, J., & Chen, Y. E. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6809-7 · Cited by 33 · see citing works

The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion

Shehata, A. H., Ahmed, A. F., Bekhit, A. A., & Heeba, G. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117679 · Cited by 30 · see citing works

Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway

Li, P., Shibata, R., Maruyama, S., Kondo, M., Ohashi, K., Ouchi, N., & Murohara, T. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00284.2010 · Cited by 28 · see citing works

Reversing Vascular Dysfunction in Rheumatoid Arthritis: Improved Augmentation Index but Not Endothelial Function With Peroxisome Proliferator–Activated Receptor γ Agonist Therapy

Ormseth, M. J., Oeser, A. M., Cunningham, A., Bian, A., Shintani, A., Solus, J. F., Tanner, S. B., & Stein, C. M. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38686 · Cited by 27 · see citing works

Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: Effect of fenofibrate treatment

Chan, D. C., Wong, A. T. Y., Yamashita, S., & Watts, G. F. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.029 · Cited by 26 · see citing works

Coronary endothelial dysfunction is associated with a reduction in coronary artery compliance and an increase in wall shear stress

Takumi, T., Yang, E., Mathew, V., Rihal, C. S., Gulati, R., Lerman, L. O., & Lerman, A. (2010) · Heart · doi:10.1136/hrt.2009.187898 · Cited by 25 · see citing works

Fenofibrate in cancer: mechanisms involved in anticancer activity

Koltai, T. (2015) · F1000Research · doi:10.12688/f1000research.6153.1 · Cited by 24 · see citing works

Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?

Dodson, P. M. (2009) · Eye · doi:10.1038/eye.2008.428 · Cited by 24 · see citing works

Regulation of the immune microenvironment by pioglitazone-loaded polylactic glycolic acid nanosphere composite scaffolds to promote vascularization and bone regeneration

Fan, S., Tan, Y., Yuan, X., Liu, C., Wu, X., Dai, T., Ni, S., Wang, J., Weng, Y., & Zhao, H. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241231452 · Cited by 22 · see citing works

Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome

Bokuda, K. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11958 · Cited by 22 · see citing works

Impact of cardiometabolic risk factors and its management on the reversion and progression of arterial stiffness

la Maza-Bustindui, N. S. D., León-Álvarez, M., Ponce-Acosta, C., Zarco-Morales, K. P., Fermín‐Martínez, C. A., Antonio‐Villa, N. E., & Bello‐Chavolla, O. Y. (2025) · npj Cardiovascular Health · doi:10.1038/s44325-025-00074-6 · Cited by 21 · see citing works

PPAR-αAgonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5′-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells

Liu, J., Lu, C., Li, F., Wang, H., He, L., Hao, Y., Chen, A. F., An, H., Wang, X., Hong, T., et al. (2011) · PPAR Research · doi:10.1155/2011/523520 · Cited by 21 · see citing works

Positive correlation of serum adipocyte fatty acid binding protein levels with carotid–femoral pulse wave velocity in geriatric population

Tsai, J., Wang, J., Lee, C., Chen, Y., & Hsu, B. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0089-x · Cited by 21 · see citing works

Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening

Ooba, N., Setoguchi, S., Sato, T., & Kubota, K. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-015935 · Cited by 20 · see citing works

Vascular effects of PPARγ activators – From bench to bedside

Marx, N., & Walcher, D. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.05.003 · Cited by 19 · see citing works

CEPT1-Mediated Phospholipogenesis Regulates Endothelial Cell Function and Ischemia-Induced Angiogenesis Through PPARα

Zayed, M. A., Jin, X., Yang, C. Y., Belaygorod, L., Engel, C., Desai, K. A., Harroun, N., Saffaf, O., Patterson, B. W., Hsu, F., et al. (2020) · Diabetes · doi:10.2337/db20-0635 · Cited by 18 · see citing works

Coronary Flow Velocity Reserve is Improved by PPAR‐α Agonist Fenofibrate in Patients with Hypertriglyceridemia

Wang, G., He, L., Liu, J., Yu, J., Feng, X., Li, F., Hao, Y., Mao, J., Hong, T., Chen, A. F., et al. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00307.x · Cited by 18 · see citing works

Molecular Pathways and Crosstalk Characterizing the Cardiorenal Syndrome

Mühlberger, I., Mönks, K., Fechete, R., Mayer, G. J., Oberbauer, R. W., Mayer, B., & Perco, P. (2012) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0121 · Cited by 16 · see citing works

How Can We Improve the Management of Vascular Risk in Type 2 Diabetes: Insights from FIELD

Steiner, G. A. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6190-7 · Cited by 16 · see citing works

Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model

Yeh, P., Wang, L., Chang, S., Yang, W., Yang, C., & Yang, C.-H. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1622020 · Cited by 15 · see citing works

Serum leptin is a predictor for central arterial stiffness in hypertensive patients

Tsai, J., Hsu, B., Lee, C., Hsieh, Y., Chen, Y., & Wang, J. (2016) · Nephrology · doi:10.1111/nep.12859 · Cited by 15 · see citing works

Angiotensin II Type-I Receptor Blocker, Candesartan, Improves Brachial-Ankle Pulse Wave Velocity Independent of Its Blood Pressure Lowering Effects in Type 2 Diabetes Patients

Ishii, H., Tsukada, T., & Yoshida, M. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1162 · Cited by 14 · see citing works

Arterial Stiffness and Emerging Biomarkers

Doumas, M. N., Papademetriou, V., Athyros, V. G., & Karagiannis, A. I. (2015) · Angiology · doi:10.1177/0003319715594291 · Cited by 13 · see citing works

Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

Tungsiripat, M., El‐Bejjani, D., Rizk, N., Dogra, V. S., O’Riordan, M. A., Ross, A. C., Hileman, C. O., Storer, N. J., Harrill, D., & McComsey, G. A. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0187 · Cited by 13 · see citing works

Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation

Powell, L. A., Crowe, P., Kankara, C. R., McPeake, J., McCance, D. R., Young, I. S., Trimble, E. R., & McGinty, A. (2012) · Clinical Science · doi:10.1042/cs20110662 · Cited by 12 · see citing works

Rosiglitazone Influences the Expression of Leukocyte Adhesion Molecules and CD14 Receptor in Type 2 Diabetes Mellitus Patients

Štulc, T., Svobodová, H., Krupickova, Z., Doležalová, R., Marinov, I., & Češka, R. (2014) · Physiological Research · doi:10.33549/physiolres.932791 · Cited by 12 · see citing works

Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production

Liu, Y., Duan, Y., Zhao, N., Zhu, X., Yu, X., Jiao, S., Song, Y., Li, S., Ma, Y., Wang, X., et al. (2022) · Antioxidants · doi:10.3390/antiox11122378 · Cited by 10 · see citing works

Capsiate-Rich Fraction of Capsicum annuum Induces Muscular Glucose Uptake, Ameliorates Rosiglitazone-Induced Adipogenesis, and Exhibits Activation of NRs Regulating Multiple Signaling Pathways

Chae, H., Cantrell, C. L., Khan, I. A., Jarret, R. L., & Khan, S. I. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c06148 · Cited by 9 · see citing works

Sodium Glucose Cotransporter-2 Inhibitors Improve Endothelial Function and Arterial Stiffness in Diabetic Individuals: A Systematic Review and Network Meta-Analysis

Sridharan, K., & Sivaramakrishnan, G. (2025) · Current Vascular Pharmacology · doi:10.2174/0115701611337138241226101956 · Cited by 9 · see citing works

Effects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (EPICAMP Study): A Double-Blind, Randomized Clinical Trial

Shokouh, P., Joharimoghadam, A., Roohafza, H., Sadeghi, M., Golabchi, A., Boshtam, M., & Sarrafzadegan, N. (2013) · PPAR Research · doi:10.1155/2013/358074 · Cited by 9 · see citing works

Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease

Magri, C. J., Gatt, N., Xuereb, R. G., & Fava, S. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.140 · Cited by 9 · see citing works

Distinct Roles of PPARs in Atherosclerosis

Wang, G., Yan, Y. K., Sun, Q., Chen, L., Qiang, L., & Liu, L. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322198 · Cited by 8 · see citing works

Juniper Berries Regulate Diabetes and Obesity Markers Through Modulating PPAR α , PPAR γ , and LXR: In Vitro and In Vivo Effects

Chae, H., Dale, O. R., Mir, T. M., Ashfaq, M. K., Avula, B., Walker, L., Khan, I. A., & Khan, S. I. (2023) · Journal of Medicinal Food · doi:10.1089/jmf.2022.0146 · Cited by 8 · see citing works

Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targets.

Demyanets, S., Huber, K., & Wojta, J. (2012) · Vascular pharmacology · doi:10.1016/j.vph.2011.12.007 · Cited by 10 · see citing works

Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants

Tsai, A. K., Steffen, B. T., Ordovás, J. M., Straka, R. J., Zhou, X., Hanson, N. Q., Arnett, D. K., & Tsai, M. Y. (2011) · Translational research · doi:10.1016/j.trsl.2011.01.014 · Cited by 7 · see citing works

Matrix Metalloproteinase-9 and Augmentation Index are Reduced with an 8-Week Green-Exercise Walking Programme

Thompson, J. E. S. (2013) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000127 · Cited by 6 · see citing works

Vascular Compliance in the Cardiometabolic Syndrome

Ganne, S., & Winer, N. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.05630.x · Cited by 6 · see citing works

The vascular microenvironment and its stem cells regulate vascular homeostasis

Wang, Y., Zhang, X., Li, X., Cheng, M., & Cui, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1544129 · Cited by 5 · see citing works

Adipose tissue and inflammation

McGinty, A., & Young, I. S. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02757.x · Cited by 5 · see citing works

Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy

Ross, A. C., Hileman, C. O., Brown, T. T., Fedarko, N. S., Storer, N. J., Labbato, D. E., & McComsey, G. A. (2012) · HIV Clinical Trials · doi:10.1310/hct1304-212 · Cited by 5 · see citing works

Exenatide increases CTRP3 gene expression in adipose cells by inhibiting adipogenesis and induces apoptosis

Gündüz, M. K., Kaymak, G., Kanbur, E., Berikten, D., & Şener, H. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105479 · Cited by 4 · see citing works

Statins and fibrates as the treatment of nonproliferative diabetic retinopathy in type 2 diabetes mellitus

Ilyina, Y., Bezditko, P., Mohamed, A. S., Zavoloka, O., & Zubkova, D. (2016) · Spektrum der Augenheilkunde · doi:10.1007/s00717-016-0300-2 · Cited by 3 · see citing works

Effect of Fibrate Treatment on Circulating Adipokine Levels: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Simental-Mendía, L. E., Simental-Mendía, M. A., Sahebkar, A., Atkin, S. L., & Jamialahmadi, T. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.102957 · Cited by 3 · see citing works

Phosphatidylserine, another player in macrophage recruitment in white adipose tissue?

Renes, J. (2010) · Adipobiology · doi:10.14748/adipo.v2.257 · Cited by 3 · see citing works

Remnant Lipoproteins: A Subfraction of Plasma Triglyceride-Rich Lipoproteins Associated with Postprandial Hyperlipidemia

Nakajima, K. (2014) · Clinical & Experimental Thrombosis and Hemostasis · doi:10.14345/ceth.14013 · Cited by 3 · see citing works

Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule‐1 Level in Type 2 Diabetic Patients with Coronary Artery Disease

Wang, G., Zhang, Z., Yu, J., Zhang, F., He, L., Wei, J., Mao, J., & Wang, X. (2008) · PPAR Research · doi:10.1155/2008/548178 · Cited by 3 · see citing works

The impact of an 8-week green-exercise programme on systemic health, and on markers associated with cardiovascular disease risk

Thompson, J. E. S. (2014) · Cardiff Metropolitan Research Repository (Cardiff Metropolitan University) · doi:10.25401/cardiffmet.20319141 · Cited by 3 · see citing works

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension

Imig, J. D. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1186477 · Cited by 2 · see citing works

Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report

Kato, J., Okonogi, H., Kanzaki, G., Katsumata, H., Nakada, Y., Sagasaki, M., Komine, K., Ito, K., Saito, T., Matsunaga, A., et al. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03612-z · Cited by 1 · see citing works

Can Pioglitazone Safeguard Patients of Lichen Planus Against Homocysteine Induced Accelerated Cardiovascular Aging and Reduced Myocardial Performance: A Systematic Review

Balani, P., Lopez, A. R., Nobleza, C. M. N., Siddiqui, M., Shah, P., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.12372 · Cited by 1 · see citing works

Author Index

(2007) · Atherosclerosis · doi:10.1016/s0021-9150(07)00579-5 · Cited by 1 · see citing works

Der metabolische Einfluss von Zigarettenrauchkondensat auf die Wirkung von Glitazonen und Sartanen bei 3T3-L1-Präadipozyten

Heinz, I. (2013)

Molecular mechanism of the anti-inflammatory effect of fenofibrate

Ford, K. A. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)

Enhancement of HDL Formation and Normalization of Intravascular HDL Remodeling

Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch11

FIELD Study Revealed Fenofibrate Reduced Need for Laser Treatment for Diabetic Retinopathy

KEECH, A. C., & Mitchell, P. L. R. (2008)

Targeting PPARs in metabolic risk management: A pharmacological and nutritional approach

Bragt, M. C. E. (2011) · doi:10.26481/dis.20111214mb

Effect of fenofibrate on the need for 1 aser treatment for diabetic retinopathy: a randomized controlled trial (FIELD)

KEECH, A. C., O'Connell, R. L., Crimet, D., dʼEmden, M. C., Laatikainen, L., Merrifield, A., Williamson, E., Tse, D., Simes, R., Taskinen, M., et al. (2008) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2008-14-3-245-256

Effects of Fenofibrate Treatment on Aortic Stiffness in Patients with Pure Hypertriglyceridemia

Efe, S. Ç., Öztürk, S., Gürbüz, A. S., Acar, E., Yılmaz, M. F., Kalkan, S., Kırma, C., & İzgi, İ. A. (2020) · Koşuyolu Heart Journal · doi:10.5578/khj.69773

New data from the FIELD study: protecting the diabetic eye

(2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.069

Diabetes, Prediabetes, Metabolic Syndrome, and Large Artery Vascular Ageing

Stehouwer, C. D. A., van der Heide, F. C. T., Kozàkovà, M., & Palombo, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00007-6

Correction of certain pathophysiological components of the cardiovascular-renal metabolic syndrome (part one): The role of fenofibrate

Gilyarevskiy, S. R. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-304

Additional file 1 of PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity

Chen, J.-Y., Wu, Y.-P., Li, C.-Y., Jheng, H.-F., Kao, L.-Z., Yang, C.-C., Leu, S.-Y., Lien, I.-C., Weng, W., Tai, H.-C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14337744

Влияние фенофибрата на необходимость лазерного лечения диабетической ретинопатии (исследование field): рандомизированное контролируемое исследование

KEECH, A. C., Mitchell, P. L. R., Summanen, P. A., O’Day, J., Т.М.Е., D., Moffitt, Taskinen, M., Simes, R. J., Tse, D., Williamson, E., et al. (2008) · HYPERTENSION

Fenofibrate lowers adiposity and corrects metabolic abnormalities, but only partially restores endothelial function in dietary obese rats

Naderali, E. K., Fatani, S. H., & Williams, G. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.029 · Cited by 18 · see citing works

PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity

Chen, J., Wu, Y., Li, C.-Y., Jheng, H., Kao, L., Yang, C.-C., Leu, S., Lien, I.-C., Weng, W., Tai, H.-C., et al. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00720-y · Cited by 44 · see citing works

Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin

Araki, T., Emoto, M., Teramura, M., Yokoyama, H., Mori, K., Hatsuda, S., Maeno, T., Shinohara, K., Koyama, H., Shoji, T., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.008 · Cited by 40 · see citing works

Effects of Peroxisome Proliferator-Activated Receptor-Gamma Activation With Pioglitazone on Plasma Adipokines in Nondiabetic Patients With Either Hypercholesterolemia or Hypertension

Barac, A., Campia, U., Matuskey, L. A., Li, L., & Panza, J. A. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.058 · Cited by 18 · see citing works

Peroxisome Proliferator–Activated Receptor-γ Activation With Pioglitazone Improves Endothelium-Dependent Dilation in Nondiabetic Patients With Major Cardiovascular Risk Factors

Campia, U., Matuskey, L. A., & Panza, J. A. (2006) · Circulation · doi:10.1161/circulationaha.105.549618 · Cited by 112 · see citing works